264 related articles for article (PubMed ID: 12008655)
1. Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Aksentijevich I; Flinn IW
Cancer Control; 2002; 9(2):99-105. PubMed ID: 12008655
[TBL] [Abstract][Full Text] [Related]
2. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Flinn IW; O'Donnell PV; Goodrich A; Vogelsang G; Abrams R; Noga S; Marcellus D; Borowitz M; Jones R; Ambinder RF
Biol Blood Marrow Transplant; 2000; 6(6):628-32. PubMed ID: 11128813
[TBL] [Abstract][Full Text] [Related]
4. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
[TBL] [Abstract][Full Text] [Related]
5. Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy.
Tsai DE; Schuster SJ; Matthies A; Moore HC; Alavi A; Juweid ME; Goldenberg DM; Stadtmauer EA
Clin Lymphoma; 2000 Jun; 1(1):62-6. PubMed ID: 11707815
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
Bolwell BJ
Semin Oncol; 1994 Aug; 21(4 Suppl 7):86-95. PubMed ID: 7916488
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphoma.
Halwani AS; Link BK
Expert Rev Anticancer Ther; 2011 Mar; 11(3):443-55. PubMed ID: 21417857
[TBL] [Abstract][Full Text] [Related]
8. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
9. Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation.
Kvalheim G; Funderud S; Kvaløy S; Gaudernack G; Beiske K; Jakobsen E; Jacobsen AB; Pihl A; Fodstad O
J Natl Cancer Inst; 1988 Oct; 80(16):1322-5. PubMed ID: 3050139
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
Gisselbrecht C; Vose J; Nademanee A; Gianni AM; Nagler A
Oncologist; 2009; 14 Suppl 2():41-51. PubMed ID: 19819923
[TBL] [Abstract][Full Text] [Related]
11. Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma.
Gisselbrecht C; Mounier N
Semin Oncol; 2003 Feb; 30(1 Suppl 2):28-33. PubMed ID: 12652462
[TBL] [Abstract][Full Text] [Related]
12. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
13. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
[TBL] [Abstract][Full Text] [Related]
14. Iodine 131 tositumomab in the treatment of non-Hodgkin's lymphoma.
Smith S; Sweetenham JW
Future Oncol; 2007 Jun; 3(3):255-62. PubMed ID: 17547519
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodies.
Winter JN; Marder RJ; Mankad B; Epstein AL
Cancer; 1988 Mar; 61(6):1082-90. PubMed ID: 3277700
[TBL] [Abstract][Full Text] [Related]
16. Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
Ansell SM; Ristow KM; Habermann TM; Wiseman GA; Witzig TE
J Clin Oncol; 2002 Sep; 20(18):3885-90. PubMed ID: 12228209
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
[TBL] [Abstract][Full Text] [Related]
20. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.
Alvarnas JC; Forman SJ
Oncology (Williston Park); 2004 Jun; 18(7):867-76; discussion 876-8, 881, 884. PubMed ID: 15255171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
